Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results

BACKGROUND: To report toxicity and early clinical outcomes of hypofractionated simultaneous integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant treatment after breast-conserving surgery. METHODS: Patients presenting early-stage breast cancer were enrolled in a ph...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiat Oncol
Autors principals: De Rose, Fiorenza, Fogliata, Antonella, Franceschini, Davide, Navarria, Piera, Villa, Elisa, Iftode, Cristina, D’Agostino, Giuseppe, Cozzi, Luca, Lobefalo, Francesca, Mancosu, Pietro, Tomatis, Stefano, Scorsetti, Marta
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5027088/
https://ncbi.nlm.nih.gov/pubmed/27639373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0701-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars